Khalid A Dahiyat.
Does nitric oxide inhalation need to be reassessed?
Ann King Edward Med Coll Jan - Mar 2006;12(1):42-6.
.. ..
Background: Inhaled nitric oxide is a drug which has been given FDA approval in 1999 but was not found prior to approval to be safe for use in premature neonates. Aim: To review and assess the studies which was done prior to its approval in order to find out what evidences the approval by the FDA was based on. Methods: A thorough search of the electronic data-base, Medline, Embase, Cinahl, Google. Conclusion: The use of this drug in treatment of the Pulmonary hypertension in premature babies is still contraversial and hold a serious untoward effects on the health, it should only used as the last ditch.
Category: Anesthesia
Keywords: Nitric Oxide. Pulmonary Hypertension. Premature Neonates.
Click here for Full Text Article
This article has been viewed 173 times
Download in Citation Manager - Print - Email - PakMediNet Member Services Submit your Research Synopsis for Free Expert analysis - Search- Feedback - Drug Index
Post and View Comments on this Article
